I for one concur, big potential but long time to go yet. But nothing has been proven yet. Its all hype at this moment. P-1 is not a dud, but it also has not been proved to be commercial or even flow, P-1 was a failure. There is alot of proving yet.
Its very dangerous to buy at these prices....
Once the selling frenzy kicks in, will go down dramaticaly. The limited 171Million shares on offer can furiate both upside and downside of the share price.
So get in quickly, so Bob and his mates at Wellington, Tallbot can get all of your money.
- Forums
- ASX - By Stock
- KAR
- position 98
position 98, page-3
Featured News
Add KAR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.37 |
Change
-0.005(0.36%) |
Mkt cap ! $1.067B |
Open | High | Low | Value | Volume |
$1.38 | $1.38 | $1.35 | $3.505M | 2.562M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 157718 | $1.37 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.38 | 29411 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 157718 | 1.365 |
5 | 104333 | 1.360 |
8 | 52438 | 1.355 |
40 | 234201 | 1.350 |
6 | 53917 | 1.345 |
Price($) | Vol. | No. |
---|---|---|
1.380 | 35700 | 2 |
1.385 | 74647 | 2 |
1.390 | 20700 | 2 |
1.395 | 87186 | 4 |
1.400 | 19840 | 3 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
KAR (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online